Healthcare of Ontario Pension Plan Trust Fund Trims Stock Holdings in Trupanion, Inc. $TRUP

Healthcare of Ontario Pension Plan Trust Fund reduced its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP) by 21.6% in the first quarter, according to its most recent filing with the SEC. The fund owned 97,457 shares of the financial services provider’s stock after selling 26,872 shares during the period. Healthcare of Ontario Pension Plan Trust Fund owned about 0.22% of Trupanion worth $2,496,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of TRUP. Parallel Advisors LLC grew its position in Trupanion by 1,831.9% in the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after acquiring an additional 1,722 shares during the last quarter. Kemnay Advisory Services Inc. bought a new stake in shares of Trupanion during the fourth quarter worth $64,000. Kelleher Financial Advisors purchased a new stake in shares of Trupanion during the third quarter valued at $74,000. Advisory Services Network LLC purchased a new stake in shares of Trupanion during the third quarter valued at $160,000. Finally, Fifth Third Bancorp boosted its stake in shares of Trupanion by 2,911.1% during the first quarter. Fifth Third Bancorp now owns 7,588 shares of the financial services provider’s stock valued at $194,000 after purchasing an additional 7,336 shares during the period.

Insider Transactions at Trupanion

In other Trupanion news, CFO Fawwad Qureshi sold 6,177 shares of the firm’s stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $22.18, for a total value of $137,005.86. Following the completion of the sale, the chief financial officer directly owned 2,081 shares in the company, valued at $46,156.58. This trade represents a 74.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO John R. Gallagher sold 3,603 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $21.69, for a total transaction of $78,149.07. Following the completion of the sale, the chief operating officer owned 33,065 shares of the company’s stock, valued at approximately $717,179.85. This trade represents a 9.83% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 17,807 shares of company stock valued at $394,452 in the last 90 days. Insiders own 5.58% of the company’s stock.

Trupanion Price Performance

TRUP opened at $24.49 on Friday. The firm has a market capitalization of $1.07 billion, a PE ratio of 41.51 and a beta of 1.39. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.73 and a quick ratio of 1.73. The business’s 50-day moving average is $24.33 and its two-hundred day moving average is $26.48. Trupanion, Inc. has a 1 year low of $21.16 and a 1 year high of $57.00.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, April 30th. The financial services provider reported $0.11 EPS for the quarter, beating the consensus estimate of $0.07 by $0.04. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The business had revenue of $384.05 million during the quarter, compared to analyst estimates of $379.77 million. During the same period in the prior year, the firm posted ($0.03) earnings per share. The company’s quarterly revenue was up 12.3% on a year-over-year basis. Research analysts anticipate that Trupanion, Inc. will post 0.55 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently commented on TRUP. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Trupanion in a research note on Monday, June 1st. Atlantic Securities set a $42.00 price objective on shares of Trupanion in a research report on Wednesday, July 15th. Zacks Research upgraded shares of Trupanion from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 24th. Cantor Fitzgerald reduced their target price on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating on the stock in a research report on Thursday, April 9th. Finally, Bank of America decreased their price target on shares of Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a research note on Tuesday, April 14th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $41.60.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.